Our long-term objective is ,to understand the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD) as a basis for therapy. Autosomal dominant polycystic kidney disease (ADPKD) is the most common lethal monogenic genetic diseases of man, affecting approximately 1 in 1,000 individuals. ADPKD leads to cystic replacement of renal tissue and progressive renal failure, requiring renal replacement therapy in half of the cases by age 50. It is a systemic disease involving the kidney, liver, pancreas, arteries and the heart. Mutations in PKD1 and PKD2 cause almost all cases of ADPKD. PKD1 and PKD2 encode polycystin-1and-2 (PC1 and PC2), respectively. We have recently shown that PC1 acts as a G-protein coupled receptor and PC2 functions as a Ca2+permeable cation channel. PC1 and PC2 receptor channel complex play a critical role in mechanosensation of fluid flow shear stress. We have shown that native PC2 functions as a Ca2+ permeable cation selective ion channel in renal epithelial cells. Mostly recently, we have shown that PC2 channel, in concert with PC1, regulates cell cycle progression by serving as a membrane anchor and directly regulates the cytosol/nuclear translocation of Id2, a transcription regulator. The major object of this renewal proposal is to continue our studies on PC2 to understand the signaling pathways mediated by polycystins and the molecular mechanisms leading to cyst formation. We will focus on 5 lines of investigation: 1) we will characterize a germline Pkd2 knockout mice we recently generated;2) we will generate adult PC2 knockout mouse models by disrupting the pore region of PC2;3) we will determine the physiological significance of PC2-ld2 interaction;4) we will develop kidney epithelial cell lines from Pkd2 mutants and their wild type littermates;5) we will study the effect of PC2 mutation on PC2 mediated signaling pathway in cells and in vivo. These studies are likely to lead to new developments of therapies that may palliate or cure ADPKD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK053357-12S1
Application #
7919198
Study Section
Special Emphasis Panel (ZRG1-RUS-E (02))
Program Officer
Rasooly, Rebekah S
Project Start
2009-09-30
Project End
2010-09-29
Budget Start
2009-09-30
Budget End
2010-09-29
Support Year
12
Fiscal Year
2009
Total Cost
$100,753
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Yao, Gang; Luo, Chong; Harvey, Michael et al. (2016) Disruption of polycystin-L causes hippocampal and thalamocortical hyperexcitability. Hum Mol Genet 25:448-58
Su, Xuefeng; Wu, Maoqing; Yao, Gang et al. (2015) Regulation of polycystin-1 ciliary trafficking by motifs at its C-terminus and polycystin-2 but not by cleavage at the GPS site. J Cell Sci 128:4063-73
Su, Xuefeng; Driscoll, Kaitlin; Yao, Gang et al. (2014) Bardet-Biedl syndrome proteins 1 and 3 regulate the ciliary trafficking of polycystic kidney disease 1 protein. Hum Mol Genet 23:5441-51
Zeng, Liling; Bai, Ming; Mittal, Amit K et al. (2013) Candidate tumor suppressor and pVHL partner Jade-1 binds and inhibits AKT in renal cell carcinoma. Cancer Res 73:5371-80
Nauli, Surya M; Jin, Xingjian; AbouAlaiwi, Wissam A et al. (2013) Non-motile primary cilia as fluid shear stress mechanosensors. Methods Enzymol 525:1-20
Freedman, Benjamin S; Lam, Albert Q; Sundsbak, Jamie L et al. (2013) Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. J Am Soc Nephrol 24:1571-86
Zhang, Peng; Luo, Ying; Chasan, Bernard et al. (2009) The multimeric structure of polycystin-2 (TRPP2): structural-functional correlates of homo- and hetero-multimers with TRPC1. Hum Mol Genet 18:1238-51
Zhou, Jing (2009) Polycystins and primary cilia: primers for cell cycle progression. Annu Rev Physiol 71:83-113
Starremans, P G; Li, X; Finnerty, P E et al. (2008) A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5'end of Pkd1. Kidney Int 73:1394-405
Sohara, Eisei; Luo, Ying; Zhang, Jingjing et al. (2008) Nek8 regulates the expression and localization of polycystin-1 and polycystin-2. J Am Soc Nephrol 19:469-76

Showing the most recent 10 out of 16 publications